Skip to the page

Data / Form D filings / ImmunoVec, Inc.

ImmunoVec, Inc.: Form D filings

ImmunoVec, Inc., a technology company in Los Angeles, CA, filed 2 Form D notices with the SEC between 2022 and 2026. The latest, on July 14, 2026, reports $12.7 million sold of a $15 million offering to 10 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
3435 Wilshire Blvd Suite 2700-84, Los Angeles, CA, 90010
Phone
(630) 802-0139
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1914272

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 14, 2026New notice$14,999,944$12,705,822$2,294,12210Jun 29, 2026sec.gov
Mar 1, 2022New notice$4,298,958$4,298,95825Nov 5, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Ryan WongExecutive Officer, Director
William WoodwardExecutive Officer, Director
Douglass LorenzenExecutive Officer, Director, Promoter
Chris LucasDirector

Other technology companies in California that filed recently

Every Form D from the week of Jul 13, 2026 · All recent filings in California · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what ImmunoVec, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.